Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-017894
Filing Date
2014-12-10
Accepted
2014-12-10 16:57:35
Documents
2
Period of Report
2014-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2264
2 schneebaumpoa.txt EX-24 4003
  Complete submission text file 0001179110-14-017894.txt   7469
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address GENVEC, INC. 65 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address
Schneebaum Marc R (Reporting) CIK: 0001396871 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 141278598